Kynuramines, metabolites of melatonin and other indoles: The resurrection of an almost forgotten class of biogenic amines

Journal of Pineal Research

Volumn 47, Issue 2, 2009, Pages 109-126

  Hardeland, Rüdigger ^a   Tan, Dun Xian ^b   Reiter, Russel J ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

5 hydroxykynuramine; AFMK; AMK; Inflammation; Mitochondria; Pyrrole ring cleavage; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

3 INDOLINONE; 5 HYDROXYKYNURENAMINE; AROMATIC COMPOUND; CINNAMIC ACID DERIVATIVE; CINNOLINONE; FREE RADICAL; INDOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; KYNURAMINE; MELATONIN; N1 ACETYL 5 METHOXYKYNURAMINE; N1 ACETYL N1 FORMYL 5 METHOXYKYNURAMINE; N1,N1 DIMETHYL 5 HYDROXYKYNURAMINE; N1.N1 DIMETHYLKYNURAMINE; NEURONAL NITRIC OXIDE SYNTHASE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CHEMICAL REACTION; DRUG EFFECT; DRUG POTENCY; HUMAN; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN MODIFICATION; REVIEW;

ANIMALS; BIOGENIC AMINES; HUMANS; INDOLES; KYNURAMINE; MELATONIN; MODELS, MOLECULAR;

EID: 68249129060     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00701.x     Document Type: Review

References (177)

1. Kaseda H, Noguchi T, Kido R. Biosynthetic routes to 2-aminoacetophenone and 2-amino-3-hydroxyacetophenone. J Biochem 1973 74 : 127 133.
2. Dorris RL. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference. J Pharmacol Methods 1982 7 : 133 137.
3. Jones TZ, Balsa D, Unzeta M, Ramsay RR. Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better. J Neural Transm 2007 114 : 707 712.
4. Balzer I, Hardeland R. Action of kynuramine in a dinoflagellate: stimulation of bioluminescence in Gonyaulax polyedra. Comp Biochem Physiol 1989 94C : 129 132. (Pubitemid 20047144)
5. Balzer I, Hardeland R. Circadian rhythmicity in the stimulation of bioluminescence by biogenic amines and MAO inhibitors in Gonyaulax polyedra. Int J Biometeorol 1991 34 : 231 234.
6. Hardeland R. The presence and function of melatonin and structurally related indoleamines in a dinoflagellate, and a hypothesis on the evolutionary significance of these tryptophan metabolites in unicellulars. Experientia 1993 49 : 614 622.
7. Hirata F, Hayaishi O, Tokuyama T, Senoh S. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974 249 : 1311 1313.
8. Hardeland R, Poeggeler B, Balzer I, Behrmann G. Common basis of photoperiodism in phylogenetically distant organisms and its possible origins. J Interdiscipl Cycle Res 1991 22 : 122 123.
9. 2-formyl-5-methoxykynuramine. J Sleep Res 1993 22 : 621.
10. Hardeland R, Poeggeler B, Balzer I, Behrmann G. A hypothesis on the evolutionary origins of photoperiodism based on circadian rhythmicity of melatonin in phylogenetically distant organisms. In : Chronobiology & Chronomedicine. Gutenbrunner C, Hildebrandt G, Moog R, eds. Lang, Frankfurt/M, 1993 pp. 113 120.
11. Tan D-X, Chen L-D, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
12. Reiter RJ, Poeggeler B, Tan D-X et al. Antioxidant capacity of melatonin: a novel action not requiring a receptor. Neuro Endocrinol Lett 1993 15 : 103 116.
13. Poeggeler B, Reiter RJ, Hardeland R et al. Melatonin and structurally-related, endogenous indoles act as potent electron donors and radical scavengers in vitro. Redox Rep 1996 2 : 179 184.
14. Hirata F, Hayaishi O. New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase. Biochem Biophys Res Commun 1972 47 : 1112 1119.
15. Shimizu T, Nomiyama S, Hirata F, Hayaishi O. Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem 1978 253 : 4700 4706.
16. Sun Y. Indoleamine 2,3-dioxygenase - a new antioxidant enzyme. Mater Med Pol 1989 21 : 244 250.
17. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991 5 : 2516 2522.
18. Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 2005 338 : 12 19.
19. King NJ, Thomas SR. Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 2007 39 : 2167 2172.
20. Hirata F, Hayaishi O. Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate. J Biol Chem 1975 250 : 5960 5966.
21. Taniguchi T, Sono M, Hirata F et al. Indoleamine 2,3-dioxygenase. Kinetic studies on the binding of superoxide anion and molecular oxygen to enzyme. J Biol Chem 1979 254 : 3288 3294.
22. Fuhrberg B, Hardeland R. Oxidation of melatonin by free radicals: catalysis by hemin. In : Cell Biological Problems in Chronobiology. Hardeland R, ed. University of Göttingen, Göttingen, 1994 pp. 75 81.
23. Hardeland R, Fuhrberg B. Ubiquitous melatonin - presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 1996 2 : 25 45.
24. Poeggeler B, Thuermann S, Dose A et al. Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs. J Pineal Res 2002 33 : 20 30.
25. Hardeland R, Poeggeler B, Niebergall R, Zelosko V. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 2003 34 : 17 25.
26. Hayaishi O, Yoshida R. Rhythms and physiological significance of indoleamine 2,3-dioxygenase. In : Biological Rhythms and Their Central Mechanism. Suda M, Hayaishi O, Nakagawa H, eds. Elsevier/North Holland, Amsterdam, 1979 pp. 133 141.
27. Hardeland R, Ressmeyer A-R, Zelosko V et al. Metabolites of melatonin: formation and properties of the methoxylated kynuramines AFMK and AMK. In : Recent Advances in Endocrinology and Reproduction: Evolutionary, Biotechnological and Clinical Applications. Haldar C, Singh SS, eds. Banaras Hindu University, Varanasi, 2004 pp. 21 38.
28. Hardeland R. Melatonin, eine ubiquitäre Substanz. Vorkommen, Wirkungen und Metabolismus außerhalb seiner klassischen Rolle. Abh Sächs Akad Wiss Math-Nat Kl, Endokrinologie Pt 2 2005 63 : 75 106.
29. Pandi-Perumal SR, Srinivasan V, Maestroni GJM et al. Melatonin - nature's most versatile biological signal? FEBS J 2006 273 : 2813 2838.
30. Hardeland R. 5-Methoxylated kynuramines - biologically active melatonin metabolites and sources of new products. In : Melatonin - From Molecules to Therapy. Pandi-Perumal SR, Cardinali DP, eds. Nova Science, Hauppauge, NY, 2007 pp. 23 32.
31. Ximenes VF, Catalani LH, Campa A. Oxidation of melatonin and tryptophan by an HRP cycle involving compound III. Biochem Biophys Res Commun 2001 287 : 130 134.
32. Rodrigues MR, Rodriguez D, Catalani LH et al. Interferon-gamma independent oxidation of melatonin by macrophages. J Pineal Res 2003 34 : 69 74.
33. 1-acetyl-5-methoxykynuramine, by activated leukocytes. J Pineal Res 2004 37 : 171 175.
34. Ximenes VF, Silva SO, Rodrigues MR et al. Superoxide-dependent oxidation of melatonin by myeloperoxidase. J Biol Chem 2005 280 : 38160 38169.
35. Ferry G, Ubeaud C, Lambert PH et al. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. Biochem J 2005 388 : 205 215.
36. 2-5-methoxykynuramine versus radical-mediated degradation. J Pineal Res 2007 42 : 291 296.
37. 2-formyl-5-methoxykynuramine. J Pineal Res 2008 44 : 115 120.
38. Ximenes VF. Optimized synthesis of the melatonin metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK). J Pineal Res 2008 45 : 297 301.
39. Tesoriere L, Allegra M, D'Arpa D et al. Reaction of melatonin with hemoglobin-derived oxoferryl radicals and inhibition of the hydroperoxide- induced hemoglobin denaturation in red blood cells. J Pineal Res 2001 31 : 114 119.
40. Tesoriere L, Avellone G, Ceraulo L et al. Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study. Free Radic Res 2001 35 : 633 642.
41. Semak I, Naumova M, Korik E et al. A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry 2005 44 : 9300 9307.
42. Uría H, Fuhrberg B, Poeggeler B et al. Photooxidation of melatonin. In : Cell Biological Problems in Chronobiology. Hardeland R, ed. University of Göttingen, Göttingen, 1994 pp. 89 99.
43. Hardeland R, Balzer I, Poeggeler B et al. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation and scavenging of free radicals. J Pineal Res 1995 18 : 104 111.
44. 2-formyl-5-methoxykynuramine= AFMK, not the corresponding kynurenine.]
45. Behrmann G, Uría H, Fuhrberg B et al. Melatonin terminiert photooxidative radikalische Reaktionsketten. Verh Dtsch Zool Ges 1995 88 : 94.
46. Burkhardt S, Poeggeler B, Tan D-X et al. Oxidation products formed from melatonin in various radical-generating systems. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 9 22.
47. 2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001 15 : 2294 2296.
48. Brömme HJ, Peschke E, Israel G. Photo-degradation of melatonin: influence of argon, hydrogenperoxide, and ethanol. J Pineal Res 2008 44 : 366 372.
49. Uría H, Hardeland R, Menéndez-Peláez A, Fuhrberg B. Extracts of the Syrian hamster Harderian gland catalyse photooxidation of melatonin. In : Cellular Rhythms and Indoleamines. Hardeland R, ed. University of Göttingen, Göttingen, 1995 pp. 140 144.
50. Behrmann G, Fuhrberg B, Hardeland R et al. Photooxidation of melatonin, 5-methoxytryptamine and 5-methoxytryptophol: aspects of photoprotection by periodically fluctuating molecules? Biometeorology 1997 14 Pt 2/2 : 258 263.
51. 2-formyl-5-methoxykynuramine formation from melatonin. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 136 141.
52. Hardeland R, Poeggeler B, Burkhardt S et al. Oxidation chemistry of melatonin: New aspects of radical reactions. In : Neuroendocrine System and Pineal Gland With Special Reference to Lifestock. Haldar C, Singh SS, eds. Banaras Hindu University, Varanasi, 2003 pp. 27 35.
53. Tan D-X, Manchester LC, Sainz RM et al. Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res 2005 39 : 185 194.
54. Hardeland R, Reiter RJ, Poeggeler B, Tan D-X. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993 17 : 347 357.
55. -) with melatonin detected by chemiluminescence. Clin Lab 2003 49 : 556.
56. Hardeland R, Niebergall R, Schoenke M, Poeggeler B. Carbonate radicals as initiators of melatonin oxidation: Chemiluminescence and formation of oxidation products. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 49 55.
57. Zelosko V, Libau K, Hardeland R. Product analyses reveal rapid and preferential conversion of melatonin to AFMK under the influence of carbonate radicals. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 56 57.
58. Tan D-X, Hardeland R, Manchester LC et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003 34 : 249 259.
59. Hardeland R. Photooxidation of melatonin: catalysis by extracts from Pterygophora californica (Phaeophyceae). In : Metabolism and Cellular Dynamics of Indoles. Hardeland R, ed. University of Göttingen, Göttingen, 1996 pp. 149 152.
60. Gawron E, Hardeland R. Photocatalytic destruction of melatonin by chlorophyll. In : Studies on Antioxidants and Their Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 1999 pp. 95 98.
61. Behrends A, Hardeland R, Ness H et al. Photocatalytic actions of the pesticide metabolite 2-hydroxyquinoxaline: destruction of antioxidant vitamines and biogenic amines - implications of organic redox cycling. Redox Rep 2004 9 : 279 288.
62. Behrends A, Riediger S, Grube S et al. Photocatalytic mechanisms of indoleamine destruction by the quinalphos metabolite 2-hydroxyquinoxaline: a study on melatonin and its precursors serotonin and N-acetylserotonin. J Environ Sci Health B 2007 42 : 599 606.
63. Schoenke M, Poeggeler B, Burkhardt S et al. A comparative study on products formed from indoleamines in radical-generating systems. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 32 38.
64. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005 27 : 119 130.
65. 2-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 2001 33 : 775 783.
66. Tan D-X, Reiter RJ, Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 197.
67. Tan D-X, Manchester LC, Reiter RJ et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998 253 : 614 620.
68. Tan D-X, Manchester LC, Reiter RJ, Plummer BF. Cyclic 3-hydroxymelatonin: a melatonin metabolite generated as a result of hydroxyl radical scavenging. Biol Signals Recept 1999 8 : 70 74.
69. Stasica P, Paneth P, Rosiak JM. Hydroxyl radical reaction with melatonin molecule: a computational study. J Pineal Res 2000 29 : 125 127.
70. Horstman JA, Wrona MZ, Dryhurst G. Further insights into the reaction of melatonin with hydroxyl radical. Bioorg Chem 2002 30 : 371 382.
71. Hardeland R. Melatonin, hormone of darkness and more - occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci 2008 65 : 2001 2018.
72. Mueller U, Hardeland R, Poeggeler B et al. Pathways of melatonin catabolism in the dinoflagellate Gonyaulax polyedra. Biol Rhythm Res 2001 32 : 465.
73. Agozzino P, Avellone G, Bongiorno D et al. Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite. J Pineal Res 2003 35 : 269 275.
74. Semak I, Korik E, Antonova M et al. Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. J Pineal Res 2008 45 : 515 523.
75. Hardeland R, Fuhrberg B, Zsizsik BK, Poeggeler B. Chemiluminescence as a tool for monitoring the oxidation of indolic and quinaldic radical scavengers. Eur J Clin Chem Clin Biochem 1997 35 : A108.
76. Zsizsik BK, Hardeland R. Indole-3-pyruvic acid as a free radical scavenger: chemiluminescence and fluorescence measurements and effects of inhibitors. In : Biological Rhythms and Antioxidative Protection. Hardeland R, ed. Cuvillier, Göttingen, 1997 pp. 147 152.
77. Hardeland R, Zsizsik BK, Fuhrberg B. Chemiluminescence during oxidation of indolic and quinaldic free-radical scavengers. J Biolum Chemilum 1998 13 : 204.
78. Hardeland R, Zsizsik BK, Poeggeler B et al. Indole-3-pyruvic and -propionic acids, kynurenic acid and related metabolites as luminophores and free-radical scavengers. Adv Exp Med Biol 1999 467 : 389 395.
79. Wendler J, Holst S, Hardeland R et al. Phenolic and indolic radical scavengers as luminophores. In : Bioluminescence and Chemiluminescence 2000. Case JF, Herring PJ, Robison BH, Haddock SHD, Kricka LJ, Stanley PE, eds. World Scientific Publishers, Singapore, 2001 pp. 255 258.
80. 2 system. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 39 48.
81. Uemura T, Kadota K. Serotonin- and melatonin-dependent light emission induced by xanthine oxidase. In : Progress in Tryptophan and Serotonin Research. Schlossberger HG, Kochen W, Linzen B, Steinhart H, eds. Walter de Gruyter, Berlin, 1984 pp. 673 676.
82. 2. J Neural Transm Suppl 1990 32 : 249 257.
83. Schuff-Werner P, Splettstosser W, Schmidt F, Huether G. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of human mononuclear and polymorphonuclear phagocytes. Eur J Clin Invest 1995 25 : 477 484.
84. Huether G, Fettkötter I, Keilhoff G, Wolf G. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J Neurochem 1997 69 : 2096 2101.
85. Uemura T, Kanashiro M, Yamano T et al. Isolation, structure, and properties of the β-carboline formed from 5-hydroxytryptamine by the superoxide anion-generating system. J Neurochem 1988 51 : 710 717.
86. Hryhorczuk LM, Rainey JM Jr., Frohman CE, Novak EA. A new metabolic pathway for N,N-dimethyltryptamine. Biol Psychiatry 1986 21 : 84 93.
87. Harthé C, Claudy D, Déchaud H et al. Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite. Life Sci 2003 73 : 1587 1597.
88. 2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats. J Pineal Res 2003 35 : 245 250.
89. Hardeland R, Pandi-Perumal SR. Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab (Lond) 2005 2 : article no. 22 [DOI R, Poeggeler B. Actions of melatonin, its structural and functional analogs in the central nervous system and the significance of metabolism. Cent Nerv Syst Agents Med Chem 2007 7 : 289 303.
90. Hardeland R, Poeggeler B. Melatonin beyond its classical functions. Open Physiol J 2008 1 : 1 23.
91. Fischer TW, Sweatman TW, Semak I et al. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 2006 20 : 1564 1566.
92. Hardeland R, Pandi-Perumal SR, Poeggeler B. Melatonin in plants - focus on a vertebrate night hormone with cytoprotective properties. Funct Plant Sci Biotechnol 2007 1 : 32 45.
93. 2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance for phytoremediation. FASEB J 2007 21 : 1724 1729.
94. Poeggeler B, Hardeland R. Observations on melatonin oxidation and metabolite release by unicellular organisms and small aquatic metazoans. In : Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites. Hardeland R, ed. Cuvillier, Göttingen, 2001 pp. 66 69.
95. 2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites. J Pineal Res 2007 42 : 261 266.
96. Hardeland R, Poeggeler B. Non-vertebrate melatonin. J Pineal Res 2003 34 : 233 241.
97. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
98. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002 47 : 2336 2348.
99. Messner M, Hardeland R, Rodenbeck A, Huether G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998 25 : 251 259.
100. Tan D-X, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in the bile of mammals. Life Sci 1999 65 : 2523 2529.
101. 2-formyl-5- methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res 2005 39 : 302 306.
102. Hopsu VK, Santti R, Glenner GG. Characterization of enzymes hydrolyzing acylnaphthylamides. 3. Role of kynurenine formamidase. J Histochem Cytochem 1966 14 : 653 657.
103. α-diformylkynurenine. Arch Biochem Biophys 1978 186 : 84 88.
104. Kelly RW, Amato F, Seamark RF. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1984 121 : 372 379.
105. Tan D-X, Manchester LC, Reiter RJ et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000 9 : 137 159.
106. 2-formyl-5-methoxykynuramine. J Pineal Res 2008 44 : 450 455.
107. Hardeland R, Uría H. On the role of melatonin in mammalian Harderian glands: does melatonin protect from free radicals generated by protoporphyrin-catalysed photooxidation? In : Cellular Rhythms and Indoleamines. Hardeland R, ed. University of Göttingen, Göttingen, 1995 pp. 145 151.
108. Tomás-Zapico C, Martínez-Fraga J, Rodríguez-Colunga MJ et al. Melatonin protects against δ-aminolevulinic acid-induced oxidative damage in male Syrian hamster Harderian glands. Int J Biochem Cell Biol 2002 34 : 544 553.
109. 1-acetyl-5- methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 2009 46 : 49 52.
110. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003 8 : 205 213.
111. Collon F, Bonnefort-Rousselot D, Yous S et al. Online H/D echange liquid chromatography as a support for the mass spectrometric identification of the oxidation products of melatonin. J Mass Spectrom 2009 44 : 318 329.
112. Rosen J, Than NN, Koch D et al. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
113. 1-Acetyl-5-methoxykynuramin (AMK). Diploma thesis. University of Göttingen, Göttingen, 2007.
114. 1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products. Redox Rep 2006 11 : 15 24.
115. Schueth A. Interaktion von Tyrosin mit dem Melatoninmetaboliten AMK. Diploma thesis. University of Göttingen, Göttingen, 2007.
116. 1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005 39 : 251 260.
117. 1-acetyl-5- methoxykynuramine contrasts with other tryptophan metabolites by a peculiar type of NO scavenging: cyclization to a cinnolinone prevents formation of unstable nitrosamines. J Pineal Res 2007 43 : 104 105.
118. 1-acetyl-5-methoxykynuramine. J Pineal Res 2007 43 : 382 388.
119. Hardeland R, Poeggeler B, Pappolla MA. Mitochondrial actions of melatonin - an endeavor to identify their adaptive and cytoprotective mechanisms. Abh Sächs Akad Wiss Math-Nat Kl, Endokrinologie Pt 4 2009 65 : in press.
120. Backhaus C, Rahman H, Scheffler S et al. NO scavenging by 3-hydroxyanthranilic acid and 3-hydroxykynurenine: N-nitrosation leads via oxadiazoles to o-quinone diazides. Nitric Oxide 2008 19 : 237 244.
121. 2-formyl-5-methoxykynuramine in Saccharomyces cerevisiae. Cytologia 2008 73 : 123 128.
122. 2-formyl-5-methoxykynuramine for their quantification using an on-line liquid chromatography-electrospray tandem mass spectrometry system. J Pineal Res 2004 36 : 64 71.
123. Martinez GR, Almeida EA, Klitzke CF et al. Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles. Endocr 2005 27 : 111 118.
124. Ma X, Idle JR, Krausz KW et al. Urinary metabolites and antioxidant products of exogenous melatonin in the mouse. J Pineal Res 2006 40 : 343 349.
125. Makino K. 5-Hydroxykynuramine (mausamine) in the urine of mouse. Biochem Biophys Res Commun 1961 5 : 481 485.
126. Makino K, Joh Y, Hasegawa F. The detection of mausamine in the brain of mouse. Biochem Biophys Res Commun 1962 6 : 432 437.
127. Gál GM, Sherman AD. Synthesis and metabolism of L-kynurenine in rat brain. J Neurochem 1978 30 : 607 613.
128. Gál GM, Sherman AD. L-Kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res 1980 5 : 223 239.
129. Johnson TD, Clarke DE. Kynuramines: their biochemistry and pharmacology. In : Quinolinic Acid and the Kynurenines. Stone TW, ed. CRC Press, Boca Raton, 1989 pp. 213 226.
130. Makino K, Joh Y, Hasegawa F, Takahashi H. The precursor of 5-hydroxykynuramine. Biochim Biophys Acta 1964 86 : 191 194.
131. Murakami Y, Makino K. Conversion of 5-hydroxykynurenine to 5-hydroxykynuramine and 4,6-dihydroxyquinoline in mouse liver homogenate. J Biochem 1968 63 : 20 24.
132. Zsizsik BK, Hardeland R. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway. Comp Biochem Physiol 2002 133C : 383 392.
133. Hardeland R. Melatonin and other tryptophan metabolites: rhythms outside the animal world and some novel, presumably universal pathways. In : Comparative Aspects of Circadian Rhythms. Fanjul-Moles ML, Aguilar-Roblero R, eds. Transworld Research Network, Trivandrum, 2008 pp. 1 17.
134. Hardeland R. Plants - sources of melatonin. In : Botanical Medicine in Clinical Practice. Watson RR, Preedy VR, eds. CABI, Wallingford, 2008 pp. 752 760.
135. 3H]tryptamine binding sites. Eur J Pharmacol 1984 106 : 661 664.
136. Charlton KG, Johnson TD, Hamed AT, Clarke DE. Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats. J Neural Transm 1983 57 : 199 211.
137. Johnson TD, Charlton KG, Clarke DE. Cardiac norepinephrine releasing action of kynuramine, an endogenous diamine derived from L-tryptophan. Life Sci 1984 35 : 2303 2310.
138. Charlton KG, Johnson TD, Clarke DE. Vasoconstrictor and norepinephrine potentiating action of 5-hydroxykynuramine in the isolated perfused rat kidney: involvement of serotonin receptors and alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1984 328 : 154 159.
139. Balzer I, Hardeland R. Circadian variations in the effects of epinephrine, kynuramine and potential MAO inhibitors on bioluminescence of Gonyaulax. In : Chronobiology & Chronomedicine. Surowiak J, Lewandowski MH, eds. Lang, Frankfurt/M. 1991 pp. 16 22.
140. Hardeland R, Balzer I. Chronobiology of unicells: multiplicity of frequencies, non-oscillatory states, photoperiodism and effects of biogenic amines. Trends Comp Biochem Physiol 1993 1 : 71 87.
141. Balzer I, Hardeland R. Photoperiodism and effects of indoleamines in a unicellular alga, Gonyaulax polyedra. Science 1991 253 : 795 797.
142. Fuhrberg B, Hardeland R. Effects of monamine oxidase inhibitors on 5-methoxyindoles in Gonyaulax polyedra. In : Metabolism and Cellular Dynamics of Indoles. Hardeland R, ed. University of Göttingen, Göttingen, 1996 pp. 77 80.
143. 2 receptors. Naunyn Schmiedebergs Arch Pharmacol 1983 323 : 149 154.
144. Charlton KG, Johnson TD, Clarke DE. Potentiation of the vasoconstriction to norepinephrine in the isolated perfused rat kidney by 5-hydroxykynuramine, an endogenous amine related to 5-hydroxytryptamine. Proc West Pharmacol Soc 1984 27 : 391 394.
145. Pomfret DW, Schenck KW, Fludzinski P, Cohen ML. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle. J Pharmacol Exp Ther 1987 241 : 465 471.
146. 2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension 1995 26 : 1056 1059.
147. Pfeuffer-Friederich I, Kilbinger H, Back W. Increase by 5-hydroxykynuramine of spontaneous acetylcholine release from myenteric neurons: mediated by serotonin M receptors. Eur J Pharmacol 1987 136 : 225 229.
148. Fu LH, Toda N. Structure-activity relationship of 5-hydroxykynurenamine analogues in isolated dog cerebral arteries. Jpn J Pharmacol 1979 29 : 789 796. (Pubitemid 10194638)
149. Okuma M, Tokuyama T, Senoh S et al. Antagonism of 5-hydroxykynurenamine against serotonin action on platelet aggregation. Proc Natl Acad Sci USA 1976 73 : 643 645.
150. Laekeman GL, Claeys M, Vrints M, Herman AG. No evidence for a physiological role of 5-hydroxykynuramine in chicken hemostasis. Agents Actions 1985 16 : 443 445.
151. Iwasaki Y, Kato Y, Ohgo S et al. Effects of indoleamines and their newly identified metabolites on prolactin release in rats. Endocrinology 1978 103 : 254 258.
152. Makino K, Takahashi H. Action of dimethylkynurenamine on blood pressure. Science 1954 120 : 544 545.
153. Makino K, Takahashi H. The synthesis of dimethyl 5-hydroxykynurenamine and its action on the blood pressure of rabbit. J Biochem 1955 42 : 559 560.
154. Kennaway DJ, Hugel HM. Mechanims of action of melatonin within the central nervous system. Anim Reprod Sci 1992 30 : 45 65.
155. Kennaway DJ, Hugel HM. Melatonin binding sites: are they receptors? Mol Cell Endocrinol 1992 88 : C1 C9.
156. Marangos PJ, Patel J, Hirata F et al. Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxykynurenamine. Life Sci 1981 29 : 259 267.
157. Kennaway DJ, Royles P, Webb H, Carbone F. Effects of protein restriction, melatonin administration, and short daylength on brain benzodiazepine receptors in prepubertal male rats. J Pineal Res 1988 5 : 455 467.
158. Dubocovich ML. Pharmacology and function of melatonin receptors. FASEB J 1988 2 : 2765 2773.
159. 125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina. Eur J Pharmacol 1989 162 : 289 299.
160. Kennaway DJ, Hugel HM, Clarke S et al. Structure-activity studies of melatonin analogues in prepubertal male rats. Aust J Biol Sci 1988 41 : 393 400.
161. Kennaway DJ, Royles P, Dunstan EA, Hugel HM. Prolactin response in Border-Leicester x merino ewes to administration of melatonin, melatonin analogues, a melatonin metabolite and 6-methoxybenzoxazolinone. Aust J Biol Sci 1986 39 : 427 433.
162. Kennaway DJ, Blake P, Webb HA. A melatonin agonist and N-acetyl-N2-formyl-5-methoxykynurenamine accelerate the reentrainment of the melatonin rhythm following a phase advance of the light-dark cycle. Brain Res 1989 495 : 349 354.
163. Mayo JC, Sainz RM, Tan DX et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005 165 : 139 149.
164. Silva SO, Rodrigues MR, Ximenes VF et al. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 2004 156 : 146 152.
165. Silva SO, Carvalho SR, Ximenes VF et al. Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils. Microbes Infect 2006 8 : 420 425.
166. Entrena A, Camacho ME, Carrión MD et al. Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 2005 48 : 8174 8181.
167. 1-acetyl-5- methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006 98 : 2023 2033.
168. 1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res 2009 [Epub ahead of print; PMID: 19437546].
169. Hardeland R. Melatonin, mitochondrial electron flux and leakage: recent findings and resolution of contradictory results. Adv Stud Biol 2009 1 : in press.
170. Acuña-Castroviejo D, Escames G, León J et al. Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2003 527 : 549 557.
171. Hardeland R, Coto-Montes A, Poeggeler B. Circadian rhythms, oxidative stress and antioxidative defense mechanisms. Chronobiol Int 2003 20 : 921 962.
172. Onuki J, Almeida EA, Medeiros MH, Di Mascio P. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5- methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005 38 : 107 115.
173. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
174. Manda K, Ueno M, Anzai K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 2008 45 : 430 438.
175. Maharaj DS, Anoopkumar-Dukie S, Glass BD et al. The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J Pineal Res 2002 32 : 257 261.
176. Maharaj DS, Walker RB, Glass BD, Daya S. 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates. J Chem Neuroanat 2003 26 : 103 107.
177. 1-acetyl-5-methoxykynuramine (AMK) with the tyrosine side-chain fragment, 4-ethylphenol. Redox Rep 2008 13 : 102 108.